The keys to control a COVID-19 outbreak in a haemodialysis unit.
COVID-19
asymptomatic carriers
dialysis
haemodialysis
outbreak
outcomes
risk factors
Journal
Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
14
05
2020
accepted:
25
05
2020
entrez:
5
9
2020
pubmed:
5
9
2020
medline:
5
9
2020
Statut:
epublish
Résumé
The high rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreading represents a challenge to haemodialysis (HD) units. While fast isolation of suspected cases plays an essential role to avoid disease outbreaks, significant rates of asymptomatic cases have recently been described. After detecting an outbreak in one of our HD clinics, wide SARS-CoV-2 screening and segregation of confirmed cases were performed. The entire clinic population, 192 patients, underwent testing for SARS-CoV-2 detection by real-time reverse-transcriptase polymerase chain reaction . We used univariate and multivariate logistic regression to define variables involved in SARS-CoV-2 infection in our dialysis unit. Later, we analysed differences between symptomatic and asymptomatic SARS-CoV-2-positive patients. In total, 22 symptomatic and 14 of the 170 asymptomatic patients had a SARS-CoV-2-positive result. Living in a nursing home/homeless [odds ratio (OR) 3.54; P = 0.026], having been admitted to the reference hospital within the previous 2 weeks (OR 5.19; P = 0.002) and sharing health-care transportation with future symptomatic (OR 3.33; P = 0.013) and asymptomatic (OR 4.73; P = 0.002) positive patients were independent risk factors for a positive test. Nine positive patients (25.7%) remained asymptomatic after a 3-week follow-up. We found no significant differences between symptomatic and asymptomatic SARS-CoV-2-positive patients. Detection of asymptomatic SARS-CoV-2-positive patients is probably one of the key points to controlling an outbreak in an HD unit. Sharing health-care transportation to the dialysis unit, living in a nursing home and having been admitted to the reference hospital within the previous 2 weeks, are major risk factors for SARS-CoV-2 infection.
Sections du résumé
BACKGROUND
BACKGROUND
The high rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreading represents a challenge to haemodialysis (HD) units. While fast isolation of suspected cases plays an essential role to avoid disease outbreaks, significant rates of asymptomatic cases have recently been described. After detecting an outbreak in one of our HD clinics, wide SARS-CoV-2 screening and segregation of confirmed cases were performed.
METHODS
METHODS
The entire clinic population, 192 patients, underwent testing for SARS-CoV-2 detection by real-time reverse-transcriptase polymerase chain reaction . We used univariate and multivariate logistic regression to define variables involved in SARS-CoV-2 infection in our dialysis unit. Later, we analysed differences between symptomatic and asymptomatic SARS-CoV-2-positive patients.
RESULTS
RESULTS
In total, 22 symptomatic and 14 of the 170 asymptomatic patients had a SARS-CoV-2-positive result. Living in a nursing home/homeless [odds ratio (OR) 3.54; P = 0.026], having been admitted to the reference hospital within the previous 2 weeks (OR 5.19; P = 0.002) and sharing health-care transportation with future symptomatic (OR 3.33; P = 0.013) and asymptomatic (OR 4.73; P = 0.002) positive patients were independent risk factors for a positive test. Nine positive patients (25.7%) remained asymptomatic after a 3-week follow-up. We found no significant differences between symptomatic and asymptomatic SARS-CoV-2-positive patients.
CONCLUSIONS
CONCLUSIONS
Detection of asymptomatic SARS-CoV-2-positive patients is probably one of the key points to controlling an outbreak in an HD unit. Sharing health-care transportation to the dialysis unit, living in a nursing home and having been admitted to the reference hospital within the previous 2 weeks, are major risk factors for SARS-CoV-2 infection.
Identifiants
pubmed: 32885797
doi: 10.1093/ckj/sfaa119
pii: sfaa119
pmc: PMC7454433
doi:
Types de publication
Journal Article
Langues
eng
Pagination
542-549Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA.
Références
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):451-457
pubmed: 32298245
Cochrane Database Syst Rev. 2020 Apr 21;4:CD013582
pubmed: 32315451
Kidney Med. 2020 Mar 26;2(3):365-366
pubmed: 32292905
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Int J Infect Dis. 2020 May;94:133-138
pubmed: 32247826
J Med Virol. 2020 Apr 10;:
pubmed: 32275074
J Infect. 2020 Apr;80(4):401-406
pubmed: 32112886
Clin Infect Dis. 2020 Jul 28;71(15):861-862
pubmed: 32201889
Nephrol Dial Transplant. 2020 May 1;35(5):737-741
pubmed: 32196116
JAMA. 2020 Feb 21;:
pubmed: 32083643
Lancet Infect Dis. 2020 Apr;20(4):410-411
pubmed: 32087116
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
N Engl J Med. 2020 May 7;382(19):1858-1859
pubmed: 32251568
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
J Nephrol. 2020 Apr;33(2):193-196
pubmed: 32207068
Neurol Sci. 2020 May;41(5):1003-1005
pubmed: 32270359
Clin J Am Soc Nephrol. 2020 May 7;15(5):717-719
pubmed: 32241778
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415
pubmed: 32271722
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168